Xphozah
Ended Awarded Last action
- Contract number
- 36C26125F0504
- Awardee
-
Ardelyx, Inc. UEI YLYTCEN9K617
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,017
Award facts
- Contract value 100% obligated
- $2,016.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94555, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Ardelyx, Inc., a for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is a Firm Fixed Price Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a ceiling value of $2,016.52 and an ultimate completion date of October 24, 2025. The contract is for the delivery of XPHOZAH (tenapanor), a medication developed by Ardelyx to treat hyperphosphatemia in patients on dialysis. This award is part of a larger $32,500,000 Blanket Purchase Agreement (BPA) and a $300,000 Federal Supply Schedule contract that Ardelyx holds with the VA, enabling the company to serve as a key supplier of specialized pharmaceutical products to the VA healthcare system. The contract does not have a socioeconomic set-aside designation, indicating that Ardelyx competed in the open market for this award.
Quick answers
Who was awarded contract 36C26125F0504?
36C26125F0504 was awarded to Ardelyx, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on September 25, 2025.
How much is contract 36C26125F0504 worth?
The government has obligated $2,017 on 36C26125F0504.
Is contract 36C26125F0504 an order under another contract?
Yes. 36C26125F0504 is a delivery order under 36F79722D0165, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125F0504 competed?
The extent of competition for 36C26125F0504 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award